An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib
Clinical trial NCT04764188 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04764188
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-10
- Primary completion
- 2027-05-10
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.